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Magnetic resonance imaging (MRI) has become one of the 
most widely used and powerful tools for non-invasive clinical 
diagnosis due to its high soft tissue contrast, spatial resolution, 
and penetration depth1. In addition, images are acquired without 
the use of ionizing radiation or radiotracers that would cause 
unwanted harmful side-effects. A considerable amount of research 
in medical MR imaging is focused on the development of contrast 
agents that can provide better delineation between healthy and 
diseased tissue. Magnetic nanoparticles (MNPs) are a major class 
of nanoscale material currently under extensive development for 
improved diagnosis of a wide range of diseases, including cancer2, 
cardiovascular disease3, and neurological disease4. The nanoscale 
dimensions of MNPs give rise to unique magnetic properties and 
the ability to function on a cellular and molecular level5. It is 
the combination of these characteristics that make MNPs such 
promising contrast agents for MRI applications.
Among the various MNPs under investigation, superparamagnetic 
iron oxide nanoparticles (SPIONs) have attracted considerable interest 
due to their excellent magnetic properties, biocompatibility6 and 
biodegradability7. While the in vivo applications of many nanoparticle-
based contrast agents are hampered by toxicity concerns, SPIONs 
of several formulations have been approved by the Food and Drug 
Administration (FDA) as MRI contrast agents. These include Lumiren® 
for bowel imaging8, Feridex IV® for liver and spleen imaging9, and 
Combidex® for lymph node metastases imaging10. Recent advances 
in this field have further improved the magnetic and physiochemical 
properties of SPIONs11, broadening their potential clinical applications. 
MR and relaxation properties of SPIONs
Principles of MRI contrast
MRI employs a strong magnetic field that aligns the magnetic moments 
of protons in a sample producing an equilibrium magnetization along 
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the z-axis (Mz) with a magnitude of M0. A radio frequency (RF) pulse, at 
a resonant frequency capable of transferring energy to protons, rotates 
their magnetic moments away from the z-axis, in phase, to an angle 
called the flip angle. The choice of flip angle depends on the imaging 
sequence applied, but it is generally the transverse plane (xy-plane), 
causing a net magnetization of Mxy. Upon removal of the RF, the 
magnetic moments of the protons relax to equilibrium1,12. The time 
required for the magnetic moments to relax to the equilibrium state, 
which is broadly termed the relaxation time, is tissue-dependent. 
MRI contrast in soft tissue is due to differences in the proton 
density, spin-lattice relaxation time (T1) and spin-spin relaxation 
time (T2) of the protons. T1 is the time constant of the exponential 
recovery process of M0 along the z-axis after an RF pulse. Protons that 
relax rapidly (short T1) recover full magnetization along the z-axis and 
produce high signal intensities. For protons that relax more slowly (long 
T1), full magnetization is not recovered before subsequent RF pulses, 
and so they inherently produce less signal and result in the so-called 
saturation effect. T1 weighted images illustrate anatomy well and are 
preferred when a clear image of  the structure is required12.
T2 is the time constant of the exponential decay of the transverse 
magnetization (Mxy) after an RF pulse. T2 is related to the amount 
of time for the precessing magnetic moments of protons to become 
randomly aligned in the xy-plane after an RF pulse, eventually resulting 
in a net magnetic moment of zero in the xy-plane. This dephasing 
process can be caused by a combination of local inhomogeneities in the 
magnetic field due to magnetic interactions of neighboring molecules 
and by macroscopic effects related to subtle variations in the external 
magnetic field. When the dephasing time accounts for both intrinsic 
molecular interactions and extrinsic magnetic field inhomogeneities 
it is termed T2*, and the images produced are considered to be 
T2* weighted. T2 weighted images are produced by eliminating the 
dephasing effects caused by extrinsic magnetic field inhomogeneities 
and accounting for the molecular interactions alone. T2 weighted images 
produce good pathological information since collections of abnormal 
fluid appear bright against the normal tissue background1.
Spin-echo (SE) pulse sequences are used to eliminate external 
magnetic field effects and can generate T1 or T2 weighted images 
based purely on molecular interactions1. This signal eliminates extrinsic 
effects and provides quantitative T2 data for T2 weighted images. In 
its most basic form, the spin-echo scans employ two RF pulses with 
flip angles of 90° and 180° that produce a spin echo. The 180° pulse 
serves to refocus the transverse magnetization, cancelling dephasing 
effects caused by inhomogeneities in the local magnetic field. The time 
between the application of the 90° pulse and the peak of the echo 
signal is termed the echo time (TE). Both TE and the time between RF 
pulse repetitions (TR) are responsible for the type of image produced. 
T1 weighted images are produced by selecting short TR (250 – 700 ms) 
and short TE (10 – 25 ms), while T2 weighted images are produced by 
long TR (> 2000 ms) and long TE (> 60 ms)13.
In most tissue, intrinsic variations of T1 and T2 are small and often 
exogenous materials are employed clinically to enhance the contrast 
between the tissue of interest and the surrounding tissue. While nearly 
all MRI contrast agents affect both T1 and T2, usually the effects of 
contrast agents are more pronounced for either T1 or T2, leading to the 
categorization of these probes as T1 or T2 contrast agents. T1 contrast 
agents are used to increase signal intensity providing positive contrast 
enhancement in T1 weighted images, whereas, T2 contrast agents 
decrease signal intensity resulting in a negative contrast enhancement 
in T2 weighted images. Currently, the most widely used clinical 
contrast agents are based on paramagnetic chelates of lanthanide 
metals such as gadolinium14. The presence of paramagnetic ions near 
water protons shortens their T1 relaxation time through coordination 
with water molecules providing increased contrast. While gadolinium 
chelates are widely used, their short blood circulation times, poor 
detection sensitivity, and toxicity concerns have led to the continued 
development of SPIONs for T2 contrast enhancement15,16.
Magnetic properties of SPIONs
The unique magnetic properties of SPIONs arise from a combination of  
their atomic composition, crystal structure, and size effects. Bulk iron 
oxide consists of both Fe2+ and Fe3+ atoms and exhibits ferromagnetic 
behavior. Large ferrimagnetic crystals of Fe3O4 are comprised of 
multiple magnetic domains that exhibit magnetic moments that are 
aligned within a domain, but between domains, magnetic moments 
are oriented in random directions17. Ferrimagnetic particles below 
a critical diameter consist of a single magnetic domain. The critical 
diameter, defined as the size at which domain boundaries are no 
longer energetically favorable, is highly dependent on the anisotropy 
of the particles, and varies for different materials18-20. For spherical 
magnetite iron oxide (Fe3O4) the critical diameter is approximately 
70 – 150 nm18,20,21. When the diameter of spherical magnetite 
particles is reduced below approximately 20 nm20, the thermal energy 
available at room temperature is greater than the magnetostatic 
energy well barrier. The magnetic dipole is free to fluctuate and as 
a consequence the particle acts like a paramagnetic Fe(2+,3+) atom. 
Since a nanoparticle comprises thousands of atoms it is described 
as superparamagnetic; it combines the high magnetization of bulk 
magnetite with the paramagnetic nature of Fe ions (Fig. 1). 
Effects of SPIONs on MRI contrast
SPIONs primarily act to alter T2 values of the water protons 
surrounding the particle. When SPIONs present in tissue are subject to 
an external magnetic field the large magnetic moments of the particles 
align to create large heterogeneous field gradients through which 
water protons diffuse. The dipolar coupling between the magnetic 
moments of water protons and the magnetic moments of particles 
cause efficient spin dephasing and T2 relaxation leading to a decrease 
in signal intensity22. The contrast provided by SPIONs in a T2 weighted 
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image is termed negative contrast enhancement since areas with high 
concentrations of SPIONs appear dark on MR images. 
While SPIONs provide efficient shortening of T2 and generate 
excellent contrast enhancement in tissue with longer T2 
characteristics, signal loss due to the presence of SPIONs can make 
it difficult to distinguish contrast enhancement in low signal body 
regions23,24. Senpan et al. have recently reported a T1 weighted 
colloidal cross-linked iron oxide nanoparticle comprised of oleate-
coated magnetite particles within a cross-linked phospholipid 
nanoemulsion25. This formulation decreased T2 effects and allowed 
positive T1 weighted contrast detection at nanomolar concentrations. 
Additionally, ultrasmall superparamagnetic iron oxide (USPIO), i.e., 
SPIONs with core diameters less than 10 nm, are capable of producing 
positive contrast in T1 weighted images26,27. While positive T1 
contrast is possible with USPIO, this benefit is at the expense of their 
T2 effects18,28. 
Another approach that has recently been investigated is the 
addition of a gadolinium chelate on the polymer coating of SPIONs29. 
This dual contrast agent efficiently reduces both T1 and T2 relaxation 
times and achieves good contrast in mice for both T1 and T2 weighted 
images. This unique combination allows for the acquisition of both 
highly detailed T1 weighted anatomical images and pathologically 
relevant T2 weighted images with a single imaging nanoprobe. In 
addition, such a contrast probe could provide enhanced T1 weighted 
imaging of brain tumors. Common clinical gadolinium chelates such 
as gadolinium diethylenetriamine penta-acetic acid (Gd-DTPA) cannot 
traverse the blood-brain barrier (BBB) without the use of invasive 
techniques30,31, limiting their application in brain tumor imaging. A 
significant advantage of SPIONs is their relatively large surface area 
which allows for the efficient addition of biologically active moieties 
such as BBB-penetrating peptides for non-invasive brain tumor 
imaging. For example, Veiseh et al. have shown that SPIONs labeled 
with chlorotoxin (CTX) peptide, a targeting agent with high affinity for 
tumors of neuroectodermal origin through binding of the membrane-
bound matrix metalloproteinase-2 complex, can pass the BBB and 
successfully target brain tumors in a transgenic mouse model32-35. 
The exclusion of Gd-DTPA from the parenchymal region signifies that 
the BBB is not compromised before or after the administration of CTX 
labeled SPIONs (Fig. 2), and highlights one advantage of SPIONs over 
commonly used Gd-chelates.
MRI acquisition methods for improved SPION detection
The detectability of SPIONs in vivo can be improved through synthesis 
techniques that enrich their magnetic properties (further discussed 
under “Important SPION design parameters” below), and through 
enhanced MRI acquisition methods that improve SPION detection. 
Acquisition methods that achieve low detection limits will be essential 
as the next generation of SPIONs move toward clinical application. 
Fig. 1 The effects of an external magnetic field on bulk magnetite (top), Fe ions (middle), and SPIONs (bottom). Before application of the magnetic field all 
magnetic moments are randomly aligned. Application of an external magnetic field aligns the moments along the z-axis of the magnetic field. The initial net 
magnetization of SPIONs is greater than Fe ions, but less than bulk magnetite. Upon removal of the magnetic field, the moments of bulk magnetite remain fixed 
along the z-axis while both Fe ions and SPIONs magnetic moments relax over time to equilibrium. 
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Lower detection limits will allow for administration of lower SPION 
dosages while improving contrast. In addition to methods that 
improve the negative contrast enhancement inherent to traditional T2 
weighted methods, new techniques that generate positive contrast 
enhancements are currently being developed.
Historically, MRI acquisition methods for the detection of 
SPIONs have been based on T2 weighted SE pulse sequences and T2* 
weighted gradient echo (GRE) pulse sequences that give quantitative 
and qualitative information about the location of SPIONs in vivo, 
respectively36-38. Recently, an effort to improve detection limits has led 
to the modification of traditional SPION pulse sequences37, as well as 
the application of nontraditional SPION pulse sequences such as fluid 
attenuated inversion-recovery (FLAIR)39,40.
The sensitivity of MRI in the detection of single SPION loaded 
cells increases linearly with increasing resolution and increases 
hyperbolically with increasing signal-to-noise ratios (SNR)37. Based 
on this observation, imaging with both high resolution and high 
SNR would give the greatest SPION detection capabilities; however, 
increasing resolution and SNR, both of which increase image 
acquisition time, would result in unreasonably long acquisition times. 
Since there are diminishing returns in increasing SNR, reduction 
in voxel (volumetric pixel) size should be of primary concern to 
maintain acceptable imaging times. With this in mind, Hyen et al. 
used fast imaging employing a steady-state acquisition (FIESTA) 
sequence based on a GRE pulse sequence that was able to detect 
femtomole quantities of SPIONs in labeled single cells in vitro37. With 
this pulse sequence, images are weighted by a ratio of T2 and T1, 
and detection limits are comparable to those of positron emission 
tomography (PET)41.
The fluid-attenuated inversion recovery (FLAIR) sequence was 
developed to nullify signals from fluid and has been shown to be useful 
in the diagnosis of central nervous system diseases42. This sequence 
first inverts the magnetic moments of protons in the z-axis before 
an additional 90° RF pulse at time TI (time between 180° and 90° 
RF pulse) tilts the magnetic moments into the xy-axis. This process 
can attenuate both tissue and/or fluid based on the chosen TI, but 
Fig. 2 Comparison of the BBB permeating ability of Gd-DTPA and NPCP-CTX. 
(a) T1 weighted MR images of N2:SmoA1 mice before and 5 min after the 
injection of Gd-DTPA. (b) colorized R2 (1/T2) maps superimposed onto proton 
density–weighted images obtained before and 48 h after the injection of 
NPCP-CTX. (c) T1 weighted MR images of N2:SmoA1 mice before and 5 min 
after the injection of Gd-DTPA obtained 48 h after NPCP-CTX administration. 
Arrows indicate blood vessels. Reprinted with permission from32, © 2010 
American Association for Cancer Research.
Fig. 3 Signal variation among adjacent slices (a–c) from an in vivo 3T FSE 3D IRON acquisition obtained in an ischemic rabbit hindlimb with two injection sites of SPION-
labeled stem cells (250 000 cells: dotted white arrow, 125 000 cells: solid white arrow). Excellent background suppression leads to clear visualization of the stem cell 
injection sites with positive contrast and a larger volume of hyperintense signals for the 250 000 cell injection site. The dashed white arrow indicates imperfections in both 
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suffers from long imaging times. Fukukura et al. recently demonstrated 
the effectiveness of a more rapid FLAIR echo-planar imaging (FLAIR EPI) 
sequence39,40 for the detection of malignant liver lesions with SPION 
contrast enhancement42. By suppressing signals from cysts, vascular 
structures, and periportal tissue, the FLAIR EPI sequence was more 
sensitive for the detection malignant liver tumors than either the T2 
weighted SE pulse sequences or the T2* weighted GRE pulse sequences 
in human patients.
Limitations of T2 contrast in low signal tissues have led to the 
development of specific pulse sequences that produce positive contrast 
in the presence of SPIONs. These methods attenuate the background 
signal so that only fluid and tissue immediately adjacent to SPIONs are 
visible in MR images (Fig. 3). The current positive contrast sequences 
are classified as selective RF pulse methods43-45, dephased methods46, 
and off-resonance methods47. Selective RF pulse methods, such 
as inversion-recovery with on-resonant water suppression (IRON), 
employ inversion of magnetization in conjunction with a spectrally-
selective on-resonant saturation pre-pulse that only generates signal 
from off-resonant protons in close proximity to SPIONs. Dephased 
methods employ a slice gradient in the region near the SPION that 
dephase background signal protons, but conserve signal from protons 
surrounding the SPION due to their induced magnetic field. Off-
resonance methods utilize spectrally selective RF pulses that excite 
and refocus the off-resonance water surrounding SPIONs, while 
suppressing on-resonance signals from surrounding tissue. In addition 
to positive contrast sequences, post-processing methods that do not 
require special sequences for acquisition of positive contrast images 
have been developed48,49. Liu et al. compared a post-processing 
susceptibility-gradient mapping (SGM) technique to IRON and the 
White Marker (dephased method) positive contrast sequences50. SGM 
more clearly delineates glioma tumors labeled with SPIONs than either 
the IRON or White Marker sequences in rats. Nevertheless, further 
studies are needed to compare the detection limit of the various 
positive contrast methods with those of the traditional spin echo 
methods. 
Important SPION design parameters 
The magnetic properties of the SPION are affected by the crystallinity 
and size of the magnetite core. In addition, surface modifications 
including polymer coatings and tissue targeting agents can have a 
profound effect on the efficiency of SPIONs as MRI contrast agents. 
These modifications can increase local concentrations of SPIONs in 
the tissue of interest while decreasing the concentration in background 
tissue. The efficiency of these contrast agents to increase the rate of 
relaxation of surrounding protons can be expressed by the relaxivity (r1, 
r2), which is defined as the slope of the plot 1/T1 or 1/T2 as a function 
of SPION concentration. By carefully considering the parameters of 
core synthesis and post synthesis modifications, materials with superior 
relaxivity properties and in vivo kinetics can be produced.
Core considerations
Synthesis methods of SPIONs have a dramatic effect on their 
crystallinity. The two most common methods are co-precipitation51-53 
and thermal decomposition54,55. Synthesis of SPIONs by 
co-precipitation of Fe2+ and Fe3+ in aqueous solutions has traditionally 
been the most utilized synthesis method56. This method typically 
results in a lack of well-defined nanocrystalline size, stoichiometry, 
and magnetism28,57. Furthermore, the production often yields both 
maghemite (Fe2O3) and magnetite. Magnetite is preferred of the two 
materials because of its superior magnetic properties58. Synthesis 
parameters of the co-precipitation method must be rigorously 
controlled so that nanocrystalline magnetite is the major product to 
maintain acceptable MR signal-enhancing effect. Thermal decomposition 
of iron organometallic compounds is a more recent approach that 
produces monocrystalline particles of stoichiometric magnetite59. The 
high temperatures of the thermal decomposition method allows for a 
higher rate of diffusion during the growth phase of the SPIONs resulting 
in improved magnetic properties that demonstrate high relaxivity. 
The core size of SPIONs has significant effects on relaxivity properties. 
The thermal decomposition synthesis method produces SPIONs with 
highly controllable, monodisperse size distributions. Through minor 
modifications to synthesis parameters, SPIONs with mean diameters 
Fig. 4 Nanoscale size effects of water soluble iron oxide nanocrystals on 
magnetism and induced MR signals. (a) TEM images of Fe3O4 nanocrystals of 
4, 6, 9, and 12 nm. (b) Size dependent T2 weighted MR images of nanocrystals 
in aqueous solution at 1.5 T. (c) Size dependent changes in color-coded MR 
images based on T2 values. (d) Graph of T2 value versus nanocrystal size. 
(e) Magnetization of nanocrystals measured by a SQUID magnetometer. 
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ranging from 4 nm to 20 nm can be produced with a narrow size 
distribution60. Fig. 4 illustrates the correlation between particle size and 
T2 relaxation due to changes in magnetic properties. As particle size is 
reduced there is a corresponding reduction in saturation magnetization 
which in turn reduces the T2 relaxation capabilities of SPIONs. This 
phenomenon is a result of increased surface-to-volume ratios due to 
decreased particle diameter. As particle size is reduced, the percentage 
of atoms found on the particle surface increases and the curvature of 
the particle surface considerably increases, resulting in significant surface 
effects. The atoms on the surface have a reduction in nearest neighbors 
resulting in unsatisfied bonds, as well as noncollinear spins, spin canting, 
and spin-glass-like behavior. These effects can severely diminish the 
saturation magnetization of small SPIONs by reducing the number of 
atoms that contribute efficiently to the particle’s magnetic moment61. 
Surface modifications
Surface coating
Passivation of the iron oxide core is necessary for successful application 
of SPIONs in vivo. The high surface-to-volume ratio of nanoparticles 
yields high surface energies, fascilitating surface oxidation which can 
have a significant effect on the magnetic properties of SPIONs58,61,62. 
In addition to surface oxidation, high surface energies can lead to 
particle aggregation or clustering in physiological environments63. 
Modification approaches for surface passivation of SPION cores 
generally provide a reduction in surface energy as well as either 
steric or electrostatic repulsion. Upon intravenous injection, SPIONs 
are subjected to protein adsorption, or opsonization, in the first step 
toward clearance from the blood stream by the reticuloendothelial 
system (RES). Evading RES uptake increases the blood half-life of 
SPIONs which is crucial for many MRI applications, as increased 
blood-circulation time maximizes the odds of SPIONs reaching their 
target tissue. A common technique to avoid opsonization and eventual 
clearance by the RES is to utilize hydrophilic coatings64 such as 
poly(ethylene glycol) (PEG)65 and zwitterionic66 polymers that resist 
protein fouling.
Many materials and coating approaches have been utilized for 
modifying the surface of SPIONs. Polymers are the most widely used 
coating materials and can be classified as hydrophilic or amphiphilic, 
neutral or charged, homopolymers or copolymers67,68. These polymers 
can be anchored on the iron oxide surface by hydrogen bonds, 
electrostatic forces or through pseudo-covalent bonding16. In general, 
the coating should provide the SPION with a hydrophilic exterior to 
increase water solubility and stability. 
The choice of coating material can have a significant effect on 
the relaxivity of SPIONs. The coordination chemistry of the inner 
capping ligand(s) and the hydrophilicity of the coating layer are 
important factors on particle relaxivity62,69. Daou et al. have shown 
that the coupling of surface coatings with the core of the SPION by 
carboxylates leads to spin canting and decreased net magnetization, 
yet this effect is not observed when coupling is performed with 
phosphonates62. Additionally, the use of hydrophilic molecules such as 
polyethylenimine (PEI) as capping ligands allows for greater hydration 
around the magnetic core and yields higher proton relaxivity than 
SPIONs capped with hydrophobic ligands such as oleic acid69.
Polymer chain length, which corresponds to coating thickness, 
also has significant effects on relaxivity. Computer simulations have 
shown the effect of coating thickness on relaxivity is determined by 
two competing factors: the physical exclusion of protons from the 
SPION’s magnetic field and the residence time for protons within the 
coating zone70. The structure of the coating layer determines which 
factor dominates. LeConte et al. studied the effects of chain length 
on relaxivity for SPIONs with a bilayer coating70. In this system, the 
inner hydrophobic layer excludes water, while the outer hydrophilic 
PEG layer allows for water diffusion in the coating zone. Increasing 
PEG chain length led to a reduction in r2 values. Here it seems that the 
exclusion of water from the core by the inner hydrophobic layer more 
than offsets any effect caused by increasing the hydrophilic PEG layer 
thickness. Recent studies by Hu et al. have shown that when water 
molecules are not excluded from regions close to the SPION core, 
r2 relaxivity is increased with increased chain length71. SPIONs with 
diameters of 3, 4, 5, and 6 nm were coated with a single polymer layer 
of either short chain diethylene glycol or long chain PEG. Modification 
with PEG leads to an increase from 29 to 47, 42 to 69, 48 to 86, and 
61 to 119 mM−1s−1 for the four SPION diameters respectively. These 
differences can be attributed to a larger water-slow diffusion layer of 
PEG modified SPIONs. Measurements of water diffusion coefficients 
in solutions of PEG of varying molecular weights indicate that water 
moves more slowly in more highly concentrated PEG environments72. 
Protons in the slow water diffusion layer spend a longer period of time 
in close proximity to the magnetic field of the SPION core allowing 
for more efficient dephasing of the magnetic moments of neighboring 
protons.
Targeting agents
Contrast agents that specifically target tissue can increase SNR by 
increasing local SPION concentration, potentially allowing for earlier 
detection of disease tissue such as small solid tumors and metastatic 
cells. Early SPIONs relied on passive targeting through the enhanced 
permeation and retention (EPR) effect which is the primary route for 
passive targeting in solid tumors. The EPR effect aids in nanoparticle 
uptake by way of leaky vasculature which allows particles with a 
hydrodynamic size generally less than 100 nm in diameter to cross 
from the vasculature into the interstitium73,74. Poor lymphatic drainage 
then aids in the entrapment of particles in solid tumors.
Alternatively, active targeting strategies provide mechanisms for 
the specific accumulation of contrast agents within diseased tissue or 
cells. These strategies are based on the targeting of unique molecular 
signatures of afflicted cells, such as over-expressed growth factors and 
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nutrient receptors75. Many types of ligands have been investigated in 
the targeting of these markers including antibodies, peptides, small 
molecules, and aptamers76. A recent study by Sun et al. illustrates the 
ability of targeting ligands to improve MR signal in diseased tissue77. In 
this study, PEG coated SPIONs were modified with CTX. Fig. 5 shows 
MR images that demonstrate tumor-specific SPION accumulation in 
tumors of a 9L xenograft mouse model. In a similar approach, Fang 
et al. modified SPIONs with either cyclic arginine-glycine-aspartic 
acid (RGD) which targets tumor endothelial cells, or CTX78,79. SPIONs 
modified with RGD (NP-RGD) or CTX (NP-CTX) show significant 
increases in r2 values in tumors post injection in a xenograft U87-MG 
tumor mouse model, while non-targeted control SPIONs do not. 
Active targeting is not only important for improving tissue targeting 
specificity, but has also been shown to improve the distribution of 
SPIONs within the targeted tissue. Improved distribution of SPIONs 
in vivo can be an important factor in maximizing relaxivity in tissue 
and cells. SPIONs tend to accumulate and even cluster in some 
specific tissue and/or cells, affecting their relaxation properties80,81. 
Transverse relaxivity first increases with increased cluster size followed 
by a marked decrease as cluster size continues to grow. Improved 
nanoparticle distribution in tissue due to active targeting has been 
demonstrated by several research groups82-84. In studies by Kievit et 
al., SPIONs were modified with both DNA for gene therapy and CTX 
Fig. 6 Histology analysis of C6 xenograft tumors showing NP distribution. (a) 
Prussian blue stained sections of tumors from mice treated with non-targeted 
(NP:DNA) and targeted (NP:DNA-CTX) nanovectors. The scale bar corresponds 
to 20 μm. (b) Images of Prussian blue stained sections at high magnification for 
better visualization of nanovector localization. The non-targeted NP:DNA treated 
tissue clearly shows more intense blue signals (indicating greater clustering) than 
the targeted NP:DNA-CTX treated tissue. The scale bar corresponds to 5 μm.  
Reprinted with permission from82. © 2010 American Chemical Society.
Fig. 5 MR anatomical image of a mouse in the coronal plane. (a) The dotted line indicates the approximate location of the axial cross-sections displayed in (c) and 
(d). Anatomical image in the (b) sagittal plane displaying the location of the 9L xenograft tumor (white arrow). Change in r2 relaxivity values for the tumor regions 
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(NP:DNA-CTX), with SPION/DNA as a non-targeted control (NP:DNA). 
Fig. 6 shows the reduction of SPION clustering in C6 tumors of a 
xenograft mouse model. The improved SPION distribution can act to 
minimize any reduction in relaxivity due to large cluster formation, 
leading to higher SNR and in turn, better delineation of tumor margins.
Multimodal imaging
SPIONs were specifically developed as an MR imaging contrast agent, 
yet advances in coating technologies have allowed for the addition of 
other functional imaging moieties including those for optical32,85,86 
(e.g., fluorophores) and nuclear imaging83,87,88 (e.g., radionuclides). 
These multifunctional SPIONs can be designed to incorporate 
complementary imaging modalities that synergistically provide more 
accurate information in vivo. Each imaging modality has its advantages 
and limitations and no one modality can give a comprehensive snap 
shot of a biological system. 
Fluorescent labeled SPIONs may serve as a platform for the next 
generation of multifunctional probes for multimodality imaging. They 
have been developed with the goal of providing optical contrast that 
will enable surgeons to intraoperatively distinguish cancer tissue from 
healthy tissue32,85. These nanoparticles provide fluorescence through 
the addition of numerous chromophores on the polymeric coating. 
SPIONs labeled with the near-infrared dye, Cy5.5, and CTX have shown 
the ability to produce both MRI and fluorescent tumor contrast in 
the brain of medulloblastoma transgenic mice (Fig. 7)32. Kumar et al. 
recently developed a SPION conjugated to Cy5.5 and myristoylated 
polyarginine peptides for translocation across the BBB79. This probe 
showed remarkable uptake by U87 human glioma cells in vitro and 
excellent delineation of stereotactically injected tumors in vivo by MRI. 
These advances in SPION design would allow for both preoperative MR 
imaging and intraoperative optical monitoring with a single imaging 
probe that could improve survival rates of brain tumor patients through 
better delineation of tumor boundaries.
PET/MRI multimodal imaging may offer significant advantages 
over either imaging modality alone. Several research groups have 
recently developed dual PET/MRI contrast probes that combine a 
SPION core with the radionuclide, Cu-64 chelated on the polymeric 
surface of the nanoparticle83,87,88. A combined PET/MRI contrast probe 
in an integrated system could obtain near perfect spatial registration 
of molecular/functional PET and anatomic/functional MRI89,90. This 
combination allows highly detailed anatomical MR images to be 
co-registered with PET images that currently have greater sensitivity 
to the location of contrast probes than clinical MRI87. While SPIONs 
with multimodal imaging capabilities have been developed, their full 
potential has yet to be realized due to a lack of integrated multimodal 
imaging instrumentation.
Conclusions and outlook
SPIONs have been extensively studied as MRI contrast agents and 
several formulations have been approved for clinical use. However, their 
widespread utility has yet to be realized due to limitations of current 
detection limits and a lack of tissue specificity. Recent developments in 
both MRI acquisition methods and SPION synthesis and postsynthesis 
modifications have led to significant improvements in SPION detection 
sensitivity and in vivo bio-distribution. Beyond modifications to current 
MRI acquisition methods that demonstrate greater SPION sensitivity in 
T2 weighted negative enhancement images, new acquisition methods 
are being developed that can provide positive contrast and potentially 
address current limitations of SPION contrast enhancement. These 
imaging techniques take advantage of the magnetic properties of 
SPIONs that are continually improving due to a better understanding 
of core synthesis parameters that affect both core crystallinity and 
size, as well as postsynthesis modifications that can have a dramatic 
effect on their magnetic properties and in vivo behavior. In addition, 
modifications of SPION surfaces with optical and nuclear imaging 
probes for multimodal imaging could improve diagnosis methods by 
combining the beneficial characteristics of each imaging modality.
The improvement of current detection limits is necessary for the 
successful translation of newly designed SPIONs to broad clinical 
application. Because of their magnetic properties and ease of 
functionalization, SPIONs have gained interest as theranostic agents 
capable of both providing diagnostic information and delivering 
therapeutics. In addition, the use of SPIONs for cell tracking in 
stem cell therapies has shown great promise. The potential of such 
applications in clinical settings is dependent on the development of 
highly sensitive imaging methods, as well as efficient contrast probes, 
Fig. 7 Ex vivo optical imaging and in vivo MR imaging of brain tumors 
from a mouse treated with Cy5.5 labeled SPIONs (left) and an untreated 
mouse (right). The optical spectrum gradient bar corresponds to increasing 
fluorescent intensity. The color gradient bar for MR images corresponds to 
increasing r2 values. Adapted with permission from32, © 2010 American 
Association for Cancer Research. 
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and will only be realized with improvements to current detection limits. 
Despite recent improvements to imaging methods that exploit 
the magnetic properties of SPIONs, there is still a need to improve 
detection of these probes in vivo. Additional research is needed to both 
optimize methods for synthesis of highly reproducible monocrystalline 
SPIONs and to gain a better understanding of the effects of polymeric 
coatings on magnetic properties. By addressing these issues researchers 
can usher in the next generation of SPIONs for MR imaging.  
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